Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Observe Medical ASA: Interim report for the third quarter and 2021

Oslo, November, 3rd, 2021 - Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the third quarter of 2021. The Company reports strong revenue growth for the Nordic portfolio, continued progress in the commercialization and go-to-market execution for Sippi® including an update on preparations for US market entry. CEO of Observe Medical, Björn Larsson commented: “We are building a Nordic-based medtech company with global reach, with the Sippi® digital urine meter as our first product. The roll-out of Sippi® is the key focus for the company, and during

BEWI announces intention to issue subsequent bonds under existing sustainability-linked bond framework

BEWI ASA (“BEWI” or “the Company”) intends to issue subsequent bonds under the existing EUR 250 million senior unsecured sustainability-linked bond framework with an outstanding amount of EUR 160 million and maturity in September 2026 (ISIN: SE0016276398) (“the Bonds”). The Company has mandated Carnegie AS, DNB Markets, a part of DNB ASA and Nordea Bank Abp as Joint Bookrunners to arrange a series of fixed income investor meetings commencing on 4 November 2021. An up to EUR 90 million tap issue of the Bonds may follow, subject to inter alia market conditions. The net proceeds from the

Nordea Bank Abp: Repurchase of own shares on 02.11.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares02.11.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 02.11.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR*Code) **XSTO 680,099 10.69 7,269,129.25XHEL 269,498 10.70 2,884,437.09CEUX 362,290 10.69 3,874,253.37AQEU 55,297 10.70 591,609.

Media Advisory: SEI expert comments on Global Methane Pledge

Today, world leaders have signed up to the Global Methane Pledge, to cut global methane emissions by 30% by 2030.  Dr Johan C.I Kuylenstierna , Research Leader at the Stockholm Environment Institute, University of York and co-author of the UNEP / CCAC* Global Methane  Assessment  comments.The Pledge is an initiative led by the US and EU, and more than 100 countries have now joined. The goal of the Pledge is to cut warming by 0.2°C and also achieve health and other development

Seadrill New Finance Limited (the “Issuer”) – Update on SeaMex restructuring

Hamilton, Bermuda | November 2, 2021- Seadrill Limited (“Seadrill” or the “Company”) (OSE: SDRL, OTCPK:SDRLF) and the Issuer announce, further to the announcements made by Seadrill and the Issuer including on June 18 2021, July 2, 2021, August 31, 2021 and September 2, 2021 (the “Previous Announcements”), completion of the business and asset purchase agreement (“SPA”) which has effected the sale of substantially all of the assets of SeaMex Ltd. (provisional liquidators appointed) (“SeaMex”), including the shares in its subsidiaries (the “SeaMex Subsidiaries”) by the joint provisional

The Board of Loomis has resolved to continue to repurchase own shares

The board of directors of Loomis AB has resolved to continue the repurchases of own shares that was initiated earlier this year. The purpose of the repurchases are to adapt Loomis’ capital structure to the company’s capital requirements and are made by virtue of the authorization granted by the annual general meeting 2021. The repurchase may commence on 4 November 2021, end not later than on 4 January 2022 and comprise an amount up to a maximum of SEK 200 million. Repurchase shall be made on Nasdaq Stockholm, on one or more occasions, at a price within the prevailing price interval

Empowering, informing and retaining volunteer research participants: Parkinson’s UK launches an online communications toolkit for researchers and research participants

Parkinson’s UK has developed an interactive web-based communications toolkit  to help researchers and participants keep in touch after they have taken part in a research study. The toolkit was created after a survey showed that 72% of people who have taken part in Parkinson's research didn't hear anything after contributing. Laurel Miller, who has Parkinson’s and was a member of the steering group behind the toolkit, said: “Researchers should use this toolkit because people want to feel that their participation in

Cessatech annonces the issuance of its first US patent covering CT001

Copenhagen, Denmark, 02 November 2021 – Cessatech A/S (“Cessatech” or the “Company”) announces that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11.160.799 to the Company, which is directed to a storage stable pre-filled and ready to use nasal spray device comprising sufentanil and ketamine and a method of treating or preventing pain in a child by use of said device.CT001 is an analgesic non-invasive nasal spray for children aged 1-17 years that experience acute pain or pain related to medical procedures. Today’s analgesic solutions often require an

Payment from Vanderlande to LED Aviation overdue

In company announcement no. 8, 15 September 2020, LED iBond International (LED iBond) announced that Vanderlande had placed an order for 50 UV-C LED-based disinfection systems for airport security checkpoints with LED Aviation, a spin-off from LED iBond. LED iBond’s role is to develop and manufacture these systems. Accordingly, the products and LED iBond’s manufacturing facilities have been approved by Intertek, Sweden. Therefore, LED iBond and LED Aviation are ready to start the manufacturing and delivery process. However, as LED Aviation is still awaiting payment from Vanderlande,

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 02.11.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 02.11.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 02.11.2021 Date 02.11.2021Exchange transaction BuyShare class ALEXAmount 410Average price/share 8.2759 EURHighest price/share 8.3000 EURLowest price/share 8.2100 EURTotal price 3,393.12 EUR The shares held by Alexandria Pankkiiriliike Oyj on 02.11.2021: ALEX 36,125 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Scandion Oncology A/S: Notice convening an Extraordinary General Meeting

We hereby convene an Extraordinary General Meeting of Scandion Oncology A/S (the “Company”) on Wednesday 17 November 2021 at 3 p.m. to be held at the Company's address Fruebjergvej 3, DK-2100 Copenhagen, Denmark.Agenda for the Extraordinary General Meeting 1. Election of chairman of the extraordinary general meeting 2. Proposal on revocation of emission mandate 3. Proposal regarding authorization to increase the Company's share capital by cash contribution 4. Proposal regarding authorization to issue warrants for existing shareholders 5. Proposal regarding authorization to issue

Terveystalo Plc: SHARE REPURCHASE 2.11.2021

Terveystalo Plc ANNOUNCEMENT  2.11.2021 Terveystalo Plc: SHARE REPURCHASE 2.11.2021 In the Helsinki Stock Exchange Trade date           2.11.2021Bourse trade         BuyShare                  TTALOAmount             18 000 SharesAverage price/ share    11,3188 EURTotal cost            203 738,40 EUR Terveystalo Plc now holds a total of 784 000 sharesincluding the shares repurchased on 2.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Borr Drilling Limited - Invitation to webcast and conference call Q3 2021 results

Borr Drilling Limited (NYSE and OSE: BORR) will release its financial results for the third quarter 2021 on Friday, November 5, 2021. A conference call and webcast will be held at 14:00 CET (9:00 AM New York Time).  The earnings report and presentation will be available from the Investor Relations section on www.borrdrilling.com. In order to listen to the presentation, you may do one of the following: a)    Webcast Please use the following link: www.incommuk.com/customers/online with access code: 286812 b)    Conference Call Dial in details, Participants: Conference ID:

BEWI – Launch of tender offer to acquire remaining shares in IZOBLOK

Reference is made previous stock exchange releases about BEWI ASA’s acquisition of a majority stake of the listed Polish company IZOBLOK Spólka Akcyjna ("IZOBLOK"), a leading European provider of Expanded Polypropylene (EPP) components to the automotive industry. BEWI currently (indirectly) owns 54.66 per cent of the shares, corresponding to 66.00 per cent of the voting rights in IZOBLOK, and is now announcing its tender offer for all outstanding shares in IZOBLOK. The total number of shares subject to the tender offer is 574 481 shares, corresponding to the remaining 45.34 per cent of

Third Quarter results 2021

Fornebu, 2nd November 2021, Ocean Yield ASA (“Ocean Yield” or the “Company”) announces results for the third quarter 2021.Highlights  The Board of Directors has declared a dividend of USD 5.70 cents per share with an equivalent of NOK 0.4810 per share. This is the 33rd consecutive quarterly dividend paid by the Company.  · EBITDA for Q3 2021 was USD 33.0 million and EBITDA adjusted for finance lease effects was USD 54.7 million.  · Net profit for the period Q3 2021 was negative USD 2.5 million, which includes an impairment of USD 16.4 million on the FPSO Dhirubhai-1 and one-off

#21-362 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-361 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

ADDvise receives order worth USD 800,000

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Masarat in Saudi Arabia, a company providing biosafety- and cleanroom services. The order is worth approximately USD 800,000 and involves design and construction of cleanroom facilities for controlled biosafety laboratories for IAU University in Saudi Arabia. Delivery of the order is planned to take place during Q2 2022.  For further information, please contact:Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se Important information: This information is by ADDvise Group AB required

Glycorex Transplantation AB: Geert Nygaard appointed as new CEO

Glycorex Transplantation AB can announce that Geert Nygaard has been appointed as Chief Executive Officer of the company and will begin serving in that role on December 15th, 2021.Geert brings over 30 years of experience in the diagnostics and life science markets from a variety of senior leadership roles with Abbott Laboratories, TECAN, Epigenomics and DAKO. After more than 20 years working abroad and extensive experience working as a CEO internationally, Geert decided to move back to Denmark. Geert has a strong commercial background supported by regulatory and quality expertise. Geert

AcouSort launches its first OEM product AcouPlasma[OPTICA][L]

AcouSort launches its first OEM product AcouPlasmaOPTICAL AcouSort launches its first OEM product, offering a unique solution that enables integrated optical measurements of blood plasma in diagnostic and analytic instruments. AcouPlasmaOptical is developed under the company’s ISO13485 quality management system and is qualified to be sold on the medical device market. AcouSort now offers evaluation kits to companies that are interested in integrating the component in their systems.   – This is a major milestone for AcouSort. We have now successfully incorporated our core technology

ADDvise receives order worth USD 1.8 million

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Cordeel, a multinational construction company. The order is worth approximately USD 1.8 million and involves construction of cleanrooms for a pharmaceutical production facility in Bulgaria for TEVA Pharmaceutical. Delivery of the order is planned to take place during Q3 2022. - The market sentiment in the laboratory and cleanroom industry is very strong. Pharmaceutical companies risk appetite is growing which makes the sales cycles shorter. The inquiry rate is now very high which gives us good visibility, says

There are no items matching the current filter
There are no more items matching the current filter
Back to top